Decapeptyl Sustained Release 22,5 mg inj. susp. prol.-rel. (pwdr. + solv.) i.m. vial + amp.
Country: Belgium
Language: English
Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
Triptorelin Pamoate 31 mg - Eq. Triptorelin 22,5 mg
Available from:
Ipsen SA-NV
ATC code:
L02AE04
INN (International Name):
Triptorelin Pamoate
Dosage:
22,5 mg
Pharmaceutical form:
Powder and solvent for prolonged-release suspension for injection
Composition:
Triptorelin Pamoate 31 mg
Administration route:
Intramuscular use
Therapeutic area:
Triptorelin
Product summary:
CTI code: 362284-01 - Pack size: 22.5 mg + 1 x Injection syringe + 2 ml + 2 x Injection needle - Commercialisation status: YES - FMD code: 03582186002742 - CNK code: 2713063 - Delivery mode: Medical prescription
Authorization status:
Commercialised: Yes
Authorization date:
2010-02-11
